文献速递神经创伤神经重症

创伤性脑损伤患者脑脊液中caspase-1水平:与颅内压及预后的相关性

Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome.
PubMed 文献 · J Neurosurg · 2020-05-01

这项前瞻性观察研究纳入21例需脑室外引流的medium至重度TBI患者,前5天每日3次采集血清和脑脊液,检测caspase-1浓度并每小时记录ICP,6个月时用GOSE评估预后。结果显示高ICP组脑脊液caspase-1的5天AUC为2452.9 pg/mL·hr,高于低ICP组的617.6 pg/mL·hr;预后不良组为1918.9 pg/mL·hr,高于预后良好组的924.5 pg/mL·hr。

要点

  • 高ICP组脑脊液caspase-1的5天AUC为2452.9 pg/mL·hr,低ICP组为617.6 pg/mL·hr。
  • 预后不良组脑脊液caspase-1的5天AUC为1918.9 pg/mL·hr,预后良好组为924.5 pg/mL·hr。
  • 伤后96小时内预后不良患者脑脊液caspase-1水平更高。

核心结论

  • 在收入神经外科ICU的TBI患者队列中,高ICP患者脑脊液炎症小体蛋白caspase-1升高,尤其在伤后第2天和第3天。
  • 伤后96小时内预后不良患者脑脊液caspase-1水平更高,且其绝对值与变化趋势均与不良预后相关。

研究设计与样本

  • 前瞻性观察性研究,纳入需脑室外引流的medium至重度TBI患者,共21例、234对血清-脑脊液样本。
  • 伤后前5天每日采集血清和脑脊液3次,用酶联免疫吸附试验检测caspase-1蛋白浓度,每小时记录ICP,6个月时用GOSE评估预后。

主要发现

  • 高ICP组脑脊液caspase-1的5天AUC为2452.9 pg/mL·hr,低ICP组为617.6 pg/mL·hr。
  • 第2天高ICP组为19.7 pg/mL vs 低ICP组1.8 pg/mL(p=0.06),第3天高ICP组为13.9 pg/mL vs 低ICP组1 pg/mL(p=0.05)。
  • 预后不良组脑脊液caspase的5天AUC为1918.9 pg/mL·hr,预后良好组为924.5 pg/mL·hr。
  • 伤后96小时内预后不良患者脑脊液caspase-1蛋白水平更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objectives of this study were to evaluate levels of inflammasome-signaling proteins in serum and CSF of patients with traumatic brain injury (TBI), and to correlate these protein levels with intracranial pressure (ICP) and clinical outcomes at 6 months after injury. METHODS: This is a prospective and observational study in patients with moderate and severe TBI who required an external ventricular drain as part of their treatment. Serum and CSF samples were collected 3 times a day for the first 5 days after TBI. The authors have determined the protein concentration of caspase-1 in the CSF and serum of patients with TBI by using commercially available enzyme-linked immunosorbent assays. The ICP value was recorded hourly. The 6-month outcome was assessed using the Glasgow Outcome Scale-Extended. RESULTS: A total of 21 patients were included in this study, and a total of 234 paired serum-CSF samples were analyzed. The area under the curve (AUC) value of caspase-1 in CSF during the 5-day period was 2452.9 pg/mL·hr in the group of patients with high ICP vs 617.6 pg/mL·hr in the patients with low ICP. The differences were mainly on day 2 (19.7 pg/mL vs 1.8 pg/mL; p = 0.06) and day 3 (13.9 pg/mL vs 1 pg/mL; p = 0.05). The AUC value of caspase in CSF during the 5-day period was 1918.9 pg/mL·hr in the group of patients with poor outcome versus 924.5 pg/mL·hr in the patients with good outcome. The protein levels of caspase-1 in CSF were higher in patients with unfavorable outcomes during the first 96 hours after TBI. CONCLUSIONS: In this cohort of patients with TBI who were admitted to the neurosurgical ICU, the inflammasome protein caspase-1 is increased in the CSF of patients with high ICP, especially on days 2 and 3 after TBI. Also the protein levels of caspase-1 in CSF were higher in patients with poor outcome during the first 96 hours after TBI. Moreover, not only the absolute value of caspase-1 in CSF but also its trend is associated with poor outcomes.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pérez-Bárcena J, Crespí C, Frontera G, et al. Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome. J Neurosurg. 2020. PMID: 32357337. doi:10.3171/2020.2.JNS193079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。